Pyridocarbazole derivatives having cgmp-pde inhibitory activity
申请人:Mochida Pharmaceutical Co., Ltd.
公开号:US06197768B1
公开(公告)日:2001-03-06
The invention relates to novel pyridocarbazole derivatives having highly selective action in inhibiting cyclic GMP-phosphodiesterase (hereinafter abbreviated as cGMP-PDE), processes for producing such derivatives, agents containing at least one of such derivatives as an active ingredient for preventing and/or treating pulmonary hypertension, ischemic heart diseases or diseases against which the cGMP-PDE inhibitory action is effective, and intermediates useful for the production of pyridocarbazole derivatives.